These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 26756888)

  • 21. Dysregulation of Rac or Rho elicits death of motor neurons and activation of these GTPases is altered in the G93A mutant hSOD1 mouse model of amyotrophic lateral sclerosis.
    Stankiewicz TR; Pena C; Bouchard RJ; Linseman DA
    Neurobiol Dis; 2020 Mar; 136():104743. PubMed ID: 31931138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sensory involvement in the SOD1-G93A mouse model of amyotrophic lateral sclerosis.
    Guo YS; Wu DX; Wu HR; Wu SY; Yang C; Li B; Bu H; Zhang YS; Li CY
    Exp Mol Med; 2009 Mar; 41(3):140-50. PubMed ID: 19293633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NRF2 activation suppresses motor neuron ferroptosis induced by the SOD1
    Yang B; Pan J; Zhang XN; Wang H; He L; Rong X; Li X; Peng Y
    Neurobiol Dis; 2023 Aug; 184():106210. PubMed ID: 37352984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subpial delivery of adeno-associated virus 9-synapsin-caveolin-1 (
    Wang S; Ichinomiya T; Savchenko P; Wang D; Sawada A; Li X; Duong T; Li W; Bonds JA; Kim EJ; Miyanohara A; Roth DM; Patel HH; Patel PM; Tadokoro T; Marsala M; Head BP
    Theranostics; 2022; 12(12):5389-5403. PubMed ID: 35910808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Death receptor 6 (DR6) antagonist antibody is neuroprotective in the mouse SOD1G93A model of amyotrophic lateral sclerosis.
    Huang G; Lee X; Bian Y; Shao Z; Sheng G; Pepinsky RB; Mi S
    Cell Death Dis; 2013 Oct; 4(10):e841. PubMed ID: 24113175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Absence of toll-like receptor 4 (TLR4) extends survival in the hSOD1 G93A mouse model of amyotrophic lateral sclerosis.
    Lee JY; Lee JD; Phipps S; Noakes PG; Woodruff TM
    J Neuroinflammation; 2015 May; 12():90. PubMed ID: 25962427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Overexpression of TDP-43 Protein in the Neuron and Oligodendrocyte Cells Causes the Progressive Motor Neuron Degeneration in the SOD1 G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis.
    Lu Y; Tang C; Zhu L; Li J; Liang H; Zhang J; Xu R
    Int J Biol Sci; 2016; 12(9):1140-9. PubMed ID: 27570488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RNS60 exerts therapeutic effects in the SOD1 ALS mouse model through protective glia and peripheral nerve rescue.
    Vallarola A; Sironi F; Tortarolo M; Gatto N; De Gioia R; Pasetto L; De Paola M; Mariani A; Ghosh S; Watson R; Kalmes A; Bonetto V; Bendotti C
    J Neuroinflammation; 2018 Mar; 15(1):65. PubMed ID: 29495962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GAB(A) receptors present higher affinity and modified subunit composition in spinal motor neurons from a genetic model of amyotrophic lateral sclerosis.
    Carunchio I; Mollinari C; Pieri M; Merlo D; Zona C
    Eur J Neurosci; 2008 Oct; 28(7):1275-85. PubMed ID: 18973555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of p38 mitogen activated protein kinase activation and mutant SOD1(G93A)-induced motor neuron death.
    Dewil M; dela Cruz VF; Van Den Bosch L; Robberecht W
    Neurobiol Dis; 2007 May; 26(2):332-41. PubMed ID: 17346981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo quantification of spinal and bulbar motor neuron degeneration in the G93A-SOD1 transgenic mouse model of ALS by T2 relaxation time and apparent diffusion coefficient.
    Niessen HG; Angenstein F; Sander K; Kunz WS; Teuchert M; Ludolph AC; Heinze HJ; Scheich H; Vielhaber S
    Exp Neurol; 2006 Oct; 201(2):293-300. PubMed ID: 16740261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ca
    Cocozza G; di Castro MA; Carbonari L; Grimaldi A; Antonangeli F; Garofalo S; Porzia A; Madonna M; Mainiero F; Santoni A; Grassi F; Wulff H; D'Alessandro G; Limatola C
    Brain Behav Immun; 2018 Oct; 73():584-595. PubMed ID: 29981425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. eGFP expression under UCHL1 promoter genetically labels corticospinal motor neurons and a subpopulation of degeneration-resistant spinal motor neurons in an ALS mouse model.
    Yasvoina MV; Genç B; Jara JH; Sheets PL; Quinlan KA; Milosevic A; Shepherd GM; Heckman CJ; Özdinler PH
    J Neurosci; 2013 May; 33(18):7890-904. PubMed ID: 23637180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The alteration of serine transporter activity in a cell line model of amyotrophic lateral sclerosis (ALS).
    Lee NY; Kim Y; Ryu H; Kang YS
    Biochem Biophys Res Commun; 2017 Jan; 483(1):135-141. PubMed ID: 28043791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Galectin-1 deficiency improves axonal swelling of motor neurones in SOD1(G93A) transgenic mice.
    Kobayakawa Y; Sakumi K; Kajitani K; Kadoya T; Horie H; Kira J; Nakabeppu Y
    Neuropathol Appl Neurobiol; 2015 Feb; 41(2):227-44. PubMed ID: 24707896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutant superoxide dismutase 1 causes motor neuron degeneration independent of cyclin-dependent kinase 5 activation by p35 or p25.
    Takahashi S; Kulkarni AB
    J Neurochem; 2004 Mar; 88(5):1295-304. PubMed ID: 15009685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human superoxide dismutase 1 overexpression in motor neurons of Caenorhabditis elegans causes axon guidance defect and neurodegeneration.
    Li J; Li T; Zhang X; Tang Y; Yang J; Le W
    Neurobiol Aging; 2014 Apr; 35(4):837-46. PubMed ID: 24126158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in glial cell activation and extracellular vesicles production precede the onset of disease symptoms in transgenic hSOD1
    Golia MT; Frigerio R; Pucci S; Sironi F; Margotta C; Pasetto L; Testori C; Berrone E; Ingravalle F; Chiari M; Gori A; Duchi R; Perota A; Bergamaschi L; D'Angelo A; Cagnotti G; Galli C; Corona C; Bonetto V; Bendotti C; Cretich M; Colombo SF; Verderio C
    Exp Neurol; 2024 Apr; 374():114716. PubMed ID: 38331161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tempol moderately extends survival in a hSOD1(G93A) ALS rat model by inhibiting neuronal cell loss, oxidative damage and levels of non-native hSOD1(G93A) forms.
    Linares E; Seixas LV; dos Prazeres JN; Ladd FV; Ladd AA; Coppi AA; Augusto O
    PLoS One; 2013; 8(2):e55868. PubMed ID: 23405225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
    Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.